Fosun International Limited Cash Flow Conversion Efficiency
Fosun International Limited cash flow conversion efficiency. Based on the latest financial reports, Fosun International Limited (FNI) has a cash flow conversion efficiency ratio of 0.037x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€7.58 Billion ≈ $8.86 Billion USD) by net assets (€205.37 Billion ≈ $240.09 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Fosun International Limited (2013–2025)
Cash flow conversion efficiency of Fosun International Limited from 2013 to 2025. This chart illustrates how Fosun International Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Fosun International Limited (FNI) stock price for real-time trading data and today's change.
Fosun International Limited Cash Flow Conversion Ratio Explained
Fosun International Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Fosun International Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Fosun International Limited ranked by their cash flow conversion efficiency. Also see Fosun International Limited stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Orla Mining Ltd
TO:OLA
|
0.139x |
|
ENAGAS A.A. ADR1/2/EO150
F:EG40
|
0.014x |
|
Banijay Group NV
AS:BNJ
|
0.186x |
|
Liechtensteinische Landesbank Aktiengesellschaft
STU:LLS1
|
-0.060x |
|
WSFS Financial Corporation
NASDAQ:WSFS
|
0.045x |
|
All Ring Tech Co Ltd
TWO:6187
|
0.139x |
|
Telephone and Data Systems Inc
NYSE:TDS
|
0.015x |
|
iRhythm Technologies Inc
NASDAQ:IRTC
|
-0.162x |
Annual Cash Flow Conversion Efficiency for Fosun International Limited (2013–2025)
The table below shows the annual cash flow conversion efficiency of Fosun International Limited from 2013 to 2025. Review Fosun International Limited free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €168.30 Billion ≈ $196.76 Billion |
€26.59 Billion ≈ $31.08 Billion |
0.158x | +16.07% |
| 2024-12-31 | €197.54 Billion ≈ $230.94 Billion |
€26.88 Billion ≈ $31.43 Billion |
0.136x | +188.94% |
| 2023-12-31 | €208.57 Billion ≈ $243.85 Billion |
€9.82 Billion ≈ $11.49 Billion |
0.047x | +433.14% |
| 2022-12-31 | €199.63 Billion ≈ $233.39 Billion |
€1.76 Billion ≈ $2.06 Billion |
0.009x | +154.64% |
| 2021-12-31 | €203.21 Billion ≈ $237.58 Billion |
€-3.29 Billion ≈ $-3.84 Billion |
-0.016x | -135.13% |
| 2020-12-31 | €193.09 Billion ≈ $225.74 Billion |
€8.89 Billion ≈ $10.39 Billion |
0.046x | +6.31% |
| 2019-12-31 | €180.92 Billion ≈ $211.52 Billion |
€7.83 Billion ≈ $9.16 Billion |
0.043x | -47.78% |
| 2018-12-31 | €160.44 Billion ≈ $187.57 Billion |
€13.30 Billion ≈ $15.55 Billion |
0.083x | -62.86% |
| 2017-12-31 | €136.41 Billion ≈ $159.48 Billion |
€30.45 Billion ≈ $35.60 Billion |
0.223x | +128.53% |
| 2016-12-31 | €122.87 Billion ≈ $143.65 Billion |
€12.00 Billion ≈ $14.03 Billion |
0.098x | +384.39% |
| 2015-12-31 | €99.55 Billion ≈ $116.39 Billion |
€-3.42 Billion ≈ $-4.00 Billion |
-0.034x | -163.78% |
| 2014-12-31 | €75.68 Billion ≈ $88.48 Billion |
€4.08 Billion ≈ $4.77 Billion |
0.054x | +2020.28% |
| 2013-12-31 | €61.30 Billion ≈ $71.67 Billion |
€155.72 Million ≈ $182.05 Million |
0.003x | -- |
About Fosun International Limited
Fosun International Limited operates in the health, happiness, wealth, and intelligent manufacturing sectors in Mainland China, Portugal, and internationally. It operates through five segments: Health, Happiness, Insurance, Asset Management, and Intelligent Manufacturing. The Health segment engages in the research, development, manufacture, sale, and trading of pharmaceutical and health products;… Read more